These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma. Sápi Z; Lukács G; Sztán M; Papp J; Oláh E Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909 [TBL] [Abstract][Full Text] [Related]
9. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas. Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy. Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974 [TBL] [Abstract][Full Text] [Related]
12. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways. Eilon T; Barash I BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984 [TBL] [Abstract][Full Text] [Related]
14. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy. Fontaine JF; Mirebeau-Prunier D; Franc B; Triau S; Rodien P; Houlgatte R; Malthièry Y; Savagner F Oncogene; 2008 Apr; 27(15):2228-36. PubMed ID: 17968324 [TBL] [Abstract][Full Text] [Related]
15. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer. Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011 [TBL] [Abstract][Full Text] [Related]
16. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168 [TBL] [Abstract][Full Text] [Related]
17. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis. van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821 [TBL] [Abstract][Full Text] [Related]
18. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information. Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649 [TBL] [Abstract][Full Text] [Related]
20. Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma. Baris O; Mirebeau-Prunier D; Savagner F; Rodien P; Ballester B; Loriod B; Granjeaud S; Guyetant S; Franc B; Houlgatte R; Reynier P; Malthiery Y Oncogene; 2005 Jun; 24(25):4155-61. PubMed ID: 15806164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]